Adverse Drug Events Associated With Sitagliptin Versus Canagliflozin for the Treatment of Patients With Type 2 Diabetes Mellitus: A Systematic Comparison Through a Meta-Analysis
Diabetes Therapy - United States
doi 10.1007/s13300-018-0481-6
Full Text
Open PDFAbstract
Available in full text
Date
August 9, 2018
Authors
Publisher
Springer Science and Business Media LLC